Carmen Valenzuela Selected Research

Carmen Valenzuela Research Topics

Disease

10	Neoplasms (Cancer) 05/2023 - 02/2004
5	COVID-19 02/2022 - 01/2020
3	Inflammation (Inflammations) 02/2023 - 02/2010
2	Hypertension (High Blood Pressure) 01/2023 - 01/2021
2	Necrosis 11/2020 - 04/2011
2	Cytokine Release Syndrome 11/2020 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 09/2010
2	Huntington Disease (Huntington's Disease) 01/2019 - 02/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Pain (Aches) 02/2022
1	Neuralgia (Stump Neuralgia) 02/2022
1	Peripheral Nerve Injuries 02/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Epilepsy (Aura) 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Pneumonia (Pneumonitis) 02/2021
1	Channelopathies 01/2021
1	Disease Progression 11/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Pulmonary Arterial Hypertension 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Atrophy 02/2016
1	Melanoma (Melanoma, Malignant) 01/2015
1	Ulcer 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Diabetic Foot 01/2013
1	Uterine Cervical Dysplasia 01/2011
1	Rheumatoid Arthritis 09/2010
1	Infections 02/2010
1	Myocardial Infarction 12/2007
1	Cardiac Arrhythmias (Arrythmia) 04/2004
1	Atrial Fibrillation 03/2003
1	Heart Failure 02/2003

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 02/2021 - 09/2008
4	CIGB-300IBA 01/2018 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 10/2011
3	itolizumabIBA 11/2020 - 01/2020
3	Casein Kinase II (Casein Kinase 2)IBA 01/2018 - 09/2008
2	Ion Channels (Ion Channel)IBA 05/2023 - 01/2021
2	Angiotensin IIIBA 01/2023 - 01/2021
2	Potassium Channels (Potassium Channel)IBA 01/2022 - 02/2010
2	Monoclonal AntibodiesIBA 11/2020 - 01/2020
2	repaglinide (Prandin)FDA Link 01/2019 - 02/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018 - 09/2008
2	elisidepsinIBA 01/2015 - 04/2011
2	Epidermal Growth Factor (EGF)IBA 01/2013 - 02/2004
2	PotassiumIBA 09/2010 - 02/2010
2	Anti-Arrhythmia AgentsIBA 04/2004 - 03/2003
1	TrabectedinIBA 05/2023
1	Pattern Recognition ReceptorsIBA 02/2023
1	resolvin D2IBA 01/2023
1	LipidsIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 02/2022
1	LigandsIBA 02/2022
1	Kv Channel-Interacting Proteins (Calsenilin)IBA 02/2022
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2022
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 02/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Interferon-gamma (Interferon, gamma)IBA 11/2020
1	InterleukinsIBA 11/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	CytokinesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	AntibodiesIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	VaccinesIBA 01/2019
1	CalciumIBA 01/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	fludarabineIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	purineIBA 01/2017
1	Activating Transcription Factor 6IBA 02/2016
1	ceramide glucosyltransferaseIBA 01/2015
1	Extracellular Matrix ProteinsIBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013
1	NucleophosminIBA 10/2011
1	Lipid Bilayers (Lipid Bilayer)IBA 04/2011
1	Protein Subunit VaccinesIBA 01/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2010
1	Diclofenac (SR 38)FDA LinkGeneric 09/2010
1	Viral DNAIBA 05/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2004
1	Hormones (Hormone)IBA 04/2004
1	Propafenone (Rythmol)FDA LinkGeneric 03/2003
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2003

Therapy/Procedure

4	Therapeutics 01/2020 - 12/2007
1	Immunomodulation 01/2020
1	Time-to-Treatment 01/2020
1	Injections 01/2018
1	Chemoradiotherapy 01/2018
1	Surgical Amputation (Amputations) 01/2013
1	Cardiomyoplasty 12/2007